Document Details
Form
Filing Date
Sep 14, 2023
Document Date
Sep 14, 2023
Form Description
SEC Staff Letter: 14A-8
Company
Neumora Therapeutics, Inc.
Issuer
NEUMORA THERAPEUTICS, INC.
Filing Formats